Because $999 May Not Keep Investors Happy

Nov 23, 2007

David Hamilton has an article at VentureBeat about how viable the business model behind companies like 23andMe will turn out to be.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients
Polygenic Risk Score, Family History Refine Breast Cancer Risk Assessment in CHEK2 Mutation Carriers
Pediatric Precision Oncology Study Matches 28 Percent of Patients to Targeted Therapies
FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance
People in the News: John Henderson, Daniel Spiegelman, Eric Schaefer, More
Ancient DNA Analysis Describes Farmer, Hunter-Gatherer Interactions In Neolithic Europe

The Scan

Genomics to Trace, Prevent

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Boost to Wolf Diversity

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

Science Papers Present Algorithm to Diagnose Slowly Progressing Diseases, Korean Genome Project

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

Menu